Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-11-21
    E.g., 2018-11-21



70 items
6:37 PM, Aug 09, 2018  |  BC Innovations | Finance

Super-sized ambitions

A trend toward super-sized initial financings is attracting a new set of deep-pocketed investors to the early stage space. These new players are making earlier commitments with hopes of guaranteeing larger ownership positions at an...
4:40 PM, Jun 07, 2018  |  BC Innovations | Finance

Deerfield goes to school

Deerfield’s fourth umbrella agreement in the last eight months is a sign the firm is getting serious about creating newcos from academic discoveries. It thinks that with preset terms and unanimous buy-in, the model provides...
12:34 PM, May 17, 2018  |  BC Innovations | Finance

Europe’s piece of the pie

With China’s rising infrastructure for life science innovation and the unabated growth of U.S. science, Europe has two cards to play that can help it compete globally: expertise in key core technologies and its centralized...
7:06 PM, May 10, 2018  |  BC Innovations | Finance

Amplifying oligos

The last five years have seen a steady stream of preclinical deals for antisense, siRNA and mRNA therapies that suggests pharmas are taking the modalities seriously as alternatives to traditional small molecules and antibodies. But...
9:42 AM, Apr 05, 2018  |  BC Innovations | Finance

Public funding highlights

Public funding highlights Selected developments and initiatives in 1Q18 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of...
6:16 PM, Mar 29, 2018  |  BC Innovations | Finance

Bug money

Despite the tremendous public health need and the introduction of regulatory incentives including expedited review and market exclusivity, venture investing in antibiotics remains modest and focused primarily on clinical assets seeking to improve on known...
10:05 AM, Mar 08, 2018  |  BC Innovations | Finance

Intelligent diligence

Roche is foraying into artificial intelligence through a suite of partnering and M&A deals that are causing it to reinvent its due diligence process. The pharma is aiming to separate fact from fiction, and accurately...
1:12 PM, Feb 22, 2018  |  BC Innovations | Finance

Bigger BRAIN Initiative

The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is preparing to push projects in three areas past the pilot phase with $169 million in new NIH grants announced in 4Q17. The aim is to...
3:07 PM, Feb 08, 2018  |  BC Innovations | Finance

External rethink

As the industry seeks to develop new ways to access external innovation, companies are re-evaluating the value of public-private partnerships, and increasingly turning to other companies for research partnerships in lieu of broad deals with...
1:20 PM, Nov 09, 2017  |  BC Innovations | Finance

The return of big

After a slow second quarter, pharmas have stepped up their activity in public-private partnerships, announcing 13 in 3Q17, compared with only five in the quarter before. The deals bring the third quarter total to 56,...